The Latest Cardiac and Vascular News
SAN FRANCISCO & OXFORD, England–(BUSINESS WIRE)–Perspectum, a leading medical imaging company, has begun work on expanding its offering by including cardiac and lung imaging in many new research projects, specifically in Coronavirus multiorgan imaging studies. Recently launched COVERSCAN and Modify are two such studies, which involve aortic and cardiac imaging using Magnetic Resonance Imaging […]
July 16, 2020 07:00 AM Eastern Daylight Time LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the fourth quarter of fiscal year 2020, which ended May 31, 2020. “Our fourth […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, August 6, 2020, the Company will release financial results for the first quarter of fiscal 2021. The Company will host a conference call to discuss the results on Thursday, August 6, 2020 at 8:00 a.m. ET. Michael R. Minogue, Chairman, […]
This approach may minimize systemic toxicity associated with amiodarone PITTSBURGH–(BUSINESS WIRE)–The University of Pittsburgh and Vivasc Therapeutics Inc. today announced a research grant awarded by the NIH National Heart, Lung, and Blood Institute, valued at approximately $327,000 for the continued development of CTP-amio, the company’s lead compound, for the treatment […]
SOUTH JORDAN, Utah, July 15, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced that it has reached an agreement in principle with […]
IRVINE, Calif., July 15, 2020 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received approval from the U.S. Food and Drug Administration (FDA) for the KONECT RESILIA aortic valved conduit (AVC), the first ready-to-implant solution for bio-Bentall procedures, […]
Topline Results from GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil, Cardiac Myosin Activator, Expected in Q4 Licensing Collaboration and Royalty Monetization Deals with Xi Jing Pharmaceuticals and RTW Investments Accelerate and Expand Development of CK-3773274, Next Generation Cardiac Myosin Inhibitor Leveraging Partnerships to Finance Build of Commercial Business SOUTH SAN FRANCISCO, […]
Accelerated Commercialization Due to COVID-19 Will Enable Providers to Offer Optimized, Efficient Care BRISBANE, Calif., July 15, 2020 /PRNewswire/ — Caption Health, a leading medical artificial intelligence (AI) company, closed its Series B funding round with $53 million to further develop and commercialize its FDA-cleared, AI-guided ultrasound technology that expands patient access to high-quality […]
ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ — Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today the pricing of its previously announced underwritten public offering of an aggregate of 2,500,000 shares of its […]
Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence MINNEAPOLIS, July 15, 2020 /PRNewswire/ — Preventice Solutions, a leader in digital healthcare solutions and remote cardiac monitoring services powered by deep learning and artificial intelligence (AI), today announced that it has raised $137M in a Series B financing to accelerate […]
